Zhu Y, Li Y, Jung CK, Song DE, Hang JF, Liu Z et al (2020) Histopathologic assessment of capsular invasion in follicular thyroid neoplasms-an observer variation study. Endocr Pathol 31(2):132–140. https://doi.org/10.1007/s12022-020-09620-7

Article  CAS  PubMed  Google Scholar 

Liu Z, Bychkov A, Jung CK, Hirokawa M, Sui S, Hong S et al (2019) Interobserver and intraobserver variation in the morphological evaluation of noninvasive follicular thyroid neoplasm with papillary-like nuclear features in Asian practice. Pathol Int 69(4):202–210. https://doi.org/10.1111/pin.12779

Article  CAS  PubMed  Google Scholar 

Cancer Genome Atlas Research N (2014) Integrated genomic characterization of papillary thyroid carcinoma. Cell 159(3):676–690. https://doi.org/10.1016/j.cell.2014.09.050

Article  CAS  Google Scholar 

Cipriani NA, Johnson DN, Sarne DH, Angelos P, Reeves W, Antic T (2022) The significance of RAS-like mutations and microRNA profiling in predicting malignancy in thyroid biopsy specimens. Endocr Pathol 33(4):446–456. https://doi.org/10.1007/s12022-022-09734-0

Article  CAS  PubMed  Google Scholar 

Baloch ZW, Asa SL, Barletta JA, Ghossein RA, Juhlin CC, Jung CK et al (2022) Overview of the 2022 WHO classification of thyroid neoplasms. Endocr Pathol 33(1):27–63. https://doi.org/10.1007/s12022-022-09707-3

Article  PubMed  Google Scholar 

Kakudo K (2022) Different threshold of malignancy for RAS-like thyroid tumors causes significant differences in thyroid nodule practice. Cancers (Basel) 14(3). https://doi.org/10.3390/cancers14030812

Nikiforov YE, Seethala RR, Tallini G, Baloch ZW, Basolo F, Thompson LD et al (2016) Nomenclature revision for encapsulated follicular variant of papillary thyroid carcinoma: a paradigm shift to reduce overtreatment of indolent tumors. JAMA Oncol 2(8):1023–1029. https://doi.org/10.1001/jamaoncol.2016.0386

Article  PubMed  PubMed Central  Google Scholar 

Lloyd RV, Osamura RY, Klöppel G, Rosai J (2017) WHO classification of tumors of endocrine organs, 4th edn. France International Agency for Research on Cancer (IARC), Lyon

Google Scholar 

Jung CK, Bychkov A, Song DE, Kim JH, Zhu Y, Liu Z et al (2021) Molecular correlates and nuclear features of encapsulated follicular-patterned thyroid neoplasms. Endocrinol Metab (Seoul) 36(1):123–133. https://doi.org/10.3803/EnM.2020.860

Article  CAS  PubMed  Google Scholar 

Cho U, Mete O, Kim MH, Bae JS, Jung CK (2017) Molecular correlates and rate of lymph node metastasis of non-invasive follicular thyroid neoplasm with papillary-like nuclear features and invasive follicular variant papillary thyroid carcinoma: the impact of rigid criteria to distinguish non-invasive follicular thyroid neoplasm with papillary-like nuclear features. Mod Pathol 30(6):810–825. https://doi.org/10.1038/modpathol.2017.9

Article  CAS  PubMed  Google Scholar 

Jung CK, Kim Y, Jeon S, Jo K, Lee S, Bae JS (2018) Clinical utility of EZH1 mutations in the diagnosis of follicular-patterned thyroid tumors. Hum Pathol 81:9–17. https://doi.org/10.1016/j.humpath.2018.04.018

Article  CAS  PubMed  Google Scholar 

Haq F, Bychkov A, Jung CK (2022) A matched-pair analysis of nuclear morphologic features between core needle biopsy and surgical specimen in thyroid tumors using a deep learning model. Endocr Pathol 33(4):472–483. https://doi.org/10.1007/s12022-022-09733-1

Article  CAS  PubMed  Google Scholar 

Bankhead P, Loughrey MB, Fernández JA, Dombrowski Y, McArt DG, Dunne PD et al (2017) QuPath: open source software for digital pathology image analysis. Sci Rep 7(1). https://doi.org/10.1038/s41598-017-17204-5

Jung CK, Hong S, Bychkov A, Kakudo K (2017) The Use of Fine-Needle Aspiration (FNA) Cytology in patients with thyroid nodules in Asia: a brief overview of studies from the working group of Asian thyroid FNA cytology. J Pathol Transl Med 51(6):571–578. https://doi.org/10.4132/jptm.2017.10.19

Article  PubMed  PubMed Central  Google Scholar 

Bychkov A, Kakudo K, Hong S (2017) Current practices of thyroid fine-needle aspiration in Asia: A missing voice. J Pathol Transl Med 51(6):517–520. https://doi.org/10.4132/jptm.2017.09.27

Article  PubMed  PubMed Central  Google Scholar 

Rossi ED, Bizzarro T, Martini M, Capodimonti S, Fadda G, Larocca LM et al (2014) Morphological parameters able to predict BRAF(V600E) -mutated malignancies on thyroid fine-needle aspiration cytology: Our institutional experience. Cancer Cytopathol 122(12):883–891. https://doi.org/10.1002/cncy.21475

Article  CAS  PubMed  Google Scholar 

Elsheikh TM, Asa SL, Chan JK, DeLellis RA, Heffess CS, LiVolsi VA et al (2008) Interobserver and intraobserver variation among experts in the diagnosis of thyroid follicular lesions with borderline nuclear features of papillary carcinoma. Am J Clin Pathol 130(5):736–744. https://doi.org/10.1309/AJCPKP2QUVN4RCCP

Article  PubMed  Google Scholar 

Lloyd RV, Erickson LA, Casey MB, Lam KY, Lohse CM, Asa SL et al (2004) Observer variation in the diagnosis of follicular variant of papillary thyroid carcinoma. Am J Surg Pathol 28(10):1336–1340. https://doi.org/10.1097/01.pas.0000135519.34847.f6

Article  PubMed  Google Scholar 

Thompson LDR, Poller DN, Kakudo K, Burchette R, Nikiforov YE, Seethala RR (2018) An international interobserver variability reporting of the nuclear scoring criteria to diagnose noninvasive follicular thyroid neoplasm with papillary-like nuclear features: a validation study. Endocr Pathol 29(3):242–249. https://doi.org/10.1007/s12022-018-9520-0

Article  PubMed  Google Scholar 

Cappola AR, Mandel SJ (2013) Molecular testing in thyroid cancer: BRAF mutation status and mortality. JAMA 309(14):1529–1530. https://doi.org/10.1001/jama.2013.3620

Article  CAS  PubMed  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE et al (2016) 2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer. Thyroid 26(1):1–133. https://doi.org/10.1089/thy.2015.0020

Article  PubMed  PubMed Central  Google Scholar 

Kim M, Jeon MJ, Oh HS, Park S, Kim TY, Shong YK et al (2018) BRAF and RAS mutational status in noninvasive follicular thyroid neoplasm with papillary-like nuclear features and invasive subtype of encapsulated follicular variant of papillary thyroid carcinoma in Korea. Thyroid 28(4):504–510. https://doi.org/10.1089/thy.2017.0382

Article  CAS  PubMed  Google Scholar 

Kimura ET, Nikiforova MN, Zhu Z, Knauf JA, Nikiforov YE, Fagin JA (2003) High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma. Cancer Res 63(7):1454–1457

CAS  PubMed  Google Scholar 

Xing M (2016) Clinical utility of RAS mutations in thyroid cancer: a blurred picture now emerging clearer. BMC Med 14:12. https://doi.org/10.1186/s12916-016-0559-9

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jung CK, Bychkov A, Kakudo K (2022) Update from the 2022 World Health Organization classification of thyroid tumors: a standardized diagnostic approach. Endocrinol Metab (Seoul) 37(5):703–718. https://doi.org/10.3803/EnM.2022.1553

Article  CAS  PubMed  Google Scholar 

Kakudo K, Liu Z, Jung CK, Lai CR (2023) Lessons learned from the diversity of thyroid nodule practice. Cancer Cytopathol 131(12):741–746. https://doi.org/10.1002/cncy.22728

Article  PubMed  Google Scholar 

Agarwal S, Bychkov A, Jung CK (2021) Emerging biomarkers in thyroid practice and research. Cancers (Basel) 14(1). https://doi.org/10.3390/cancers14010204

Choden S, Keelawat S, Jung CK, Bychkov A (2020) VE1 immunohistochemistry improves the limit of genotyping for detecting BRAF(V600E) mutation in papillary thyroid cancer. Cancers (Basel) 12(3):596. https://doi.org/10.3390/cancers12030596

Article  CAS  PubMed  Google Scholar 

Kim M, Jeon S, Jung CK (2023) Preoperative risk stratification of follicular-patterned thyroid lesions on core needle biopsy by histologic subtyping and RAS variant-specific immunohistochemistry. Endocr Pathol 34(2):247–256. https://doi.org/10.1007/s12022-023-09763-3

Article  CAS  PubMed  Google Scholar 

Chang S, Choi YL, Shim HS, Lee GK, Ha SY (2022) Korean cardiopulmonary pathology study G. Usefulness of BRAF VE1 immunohistochemistry in non-small cell lung cancers: a multi-institutional study by 15 pathologists in Korea. J Pathol Transl Med 56(6):334–341. https://doi.org/10.4132/jptm.2022.08.22

Article  PubMed  PubMed Central  Google Scholar 

Lasota J, Kowalik A, Felisiak-Golabek A, Inaguma S, Wang ZF, Pieciak L et al (2017) SP174, NRAS Q61R mutant-specific antibody, cross-reacts with KRAS Q61R mutant protein in colorectal carcinoma. Arch Pathol Lab Med 141(4):564–568. https://doi.org/10.5858/arpa.2016-0147-OA

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rossi ED, Pantanowitz L (2023) Typical “BRAFV600E-like” atypia in papillary thyroid carcinoma: a morphologic sign of a driver mutation. Endocr Pathol 34(2):265–266. https://doi.org/10.1007/s12022-023-09765-1

Article  PubMed  Google Scholar 

Turchini J, Sioson L, Clarkson A, Sheen A, Delbridge L, Glover A et al (2023) The presence of typical “BRAFV600E-like” atypia in papillary thyroid carcinoma is highly specific for the presence of the BRAFV600E mutation. Endocr Pathol 34(1):112–118. https://doi.org/10.1007/s12022-022-09747-9

Article  CAS  PubMed  Google Scholar 

Arora SK, Dey P (2012) Intranuclear peudoinclusions: morphology, pathogenesis, and significance. Diagn Cytopathol 40(8):741–744. https://doi.org/10.1002/dc.21714

Article  PubMed  Google Scholar 

Aiad H, Abdou A, Bashandy M, Said A, Ezz-Elarab S, Zahran A (2009) Computerized nuclear morphometry in the diagnosis of thyroid lesions with predominant follicular pattern. Ecancermedicalscience 3:146. https://doi.org/10.3332/ecancer.2009.146

Article  PubMed  PubMed Central